Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DIEBOLD NIXDORF, IncDBD · Entity 4421 | Director | May 24, 2018 | May 24, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DIEBOLD NIXDORF, Inc
Report date May 24, 2018 · Filed May 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 64,531 |
Reported balance
After 2018-05-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-24 · Purchase · Acquired 3,000 · Balance 64,531 F1: Number includes Deferred Shares. F2: Number includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Number includes Deferred Shares.
F2: Number includes restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CROSS COUNTRY HEALTHCARE INC
Report date July 21, 2026 · Filed July 21, 2026
Section 16 reporting ended · disclosed 2026-07-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-21 transaction · row 1
1 source rowRow 1 · 2026-07-21 · Disposition to issuer · Disposed 114,331 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectBy family trust | 0 |
Reported balance
After 2026-07-21 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-07-21 · Disposition to issuer · Disposed 79,918 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. F3: These shares are held in a trust for the benefit of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2)
F2: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration.
F3: These shares are held in a trust for the benefit of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 21, 2026 Filed Jul 21, 2026 20:10 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Disposition to issuerCommon Stock | 79,918 | $13.25 | $1,058,913.50 |
DisclosureSEC source: 0001012975-26-000691 · form4.xml · nonDerivative · entry 2 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By family trust Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2 · kind: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. F3 · ownership.nature: These shares are held in a trust for the benefit of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| July 21, 2026 Filed Jul 21, 2026 20:10 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | Disposition to issuerCommon Stock | 114,331 | $13.25 | $1,514,885.75 |
DisclosureSEC source: 0001012975-26-000691 · form4.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2026, by and among Cross Country Healthcare, Inc., a Delaware corporation (the "Issuer"), KL Criss Cross Intermediate, LLC, a Delaware limited liability company ("Parent"), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, (continued in footnote 2) F2 · kind: at the effective time of the Merger (the "Effective Time"), each (i) share of Issuer common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was automatically converted into the right to receive $13.25 in cash (the "Merger Consideration") and (ii) each restricted stock award with respect to shares of Common Stock outstanding immediately prior to the Effective Time was fully vested, cancelled and converted into the right to receive an amount in cash equal to the number of shares of Common Stock subject to such award immediately prior to the Effective Time multiplied by the Merger Consideration. Read SEC document |
| December 18, 2025 Filed Dec 22, 2025 12:23 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 18,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-25-000964 · form4.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,331 F1 · shares: These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:15 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 9,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011801 · form4.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,651 F1 · shares: These restricted shares of common stock will vest June 1, 2025. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:09 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 5,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012926 · form4.xml · nonDerivative · entry 3 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,730 F3 · shares: These restricted shares of common stock will vest June 1, 2024. Read SEC document |
| March 10, 2023 Filed Jun 5, 2023 20:09 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GiftCommon Stock | 79,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012926 · form4.xml · nonDerivative · entry 2 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By family trust Disclosed balance after: 79,918 F1 · kind: This transaction involved the reporting person's gift of shares to a family trust for which the reporting person's spouse serves as trustee. F2 · ownership.nature: These shares are held in a trust for the benefit of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 10, 2023 Filed Jun 5, 2023 20:09 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GiftCommon Stock | 79,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-012926 · form4.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,918 F1 · kind: This transaction involved the reporting person's gift of shares to a family trust for which the reporting person's spouse serves as trustee. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 21:55 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 7,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-014202 · form4.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,836 F1 · shares: These restricted shares of common stock will vest June 1, 2023. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:53 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 6,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005347 · form4.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,635 F1 · shares: These restricted shares of common stock will vest June 1, 2022. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 18:32 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 17,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-20-000525 · edgar.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,972 F1 · shares: These restricted shares of common stock will vest on June 1, 2021. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 20:17 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 10,000 | $7.28 | $72,800.00 |
DisclosureSEC source: 0001012975-20-000326 · edgar.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,056 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.2825 to $7.29, inclusive. The reporting person undertakes to provide to Cross Country Healthcare, Inc., any security holder of Cross Country Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 22:08 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 15,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-19-000404 · edgar.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,056 F1 · shares: These restricted shares of common stock vest in three equal installments. The installments will vest on June 1, 2020, June 1, 2021, and June 1, 2022. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 17:30 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock | 9,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000483 · edgar.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,584 F1 · shares: The restricted shares of common stock will vest in three equal installments. The installments will vest on June 1, 2019, June 1, 2020 and June 1, 2021. Read SEC document |
| May 24, 2018 Filed May 24, 2018 20:33 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | PurchaseCommon Shares | 3,000 | $11.59 | $34,764.00 |
DisclosureSEC source: 0000028823-18-000117 · wf-form4_152719397465632.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,531 F1 · balance_after: Number includes Deferred Shares. F2 · balance_after: Number includes restricted stock units. Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 20:32 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | GrantCommon Shares | 9,928 | $0.00 | $0.00 |
DisclosureSEC source: 0000028823-18-000093 · wf-form4_152486114779839.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,531 F1 · shares: Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock. F2 · balance_after: Number includes restricted stock units. F3 · balance_after: Number includes Deferred Shares. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 21:43 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | PurchaseCommon Shares | 4,000 | $16.74 | $66,977.60 |
DisclosureSEC source: 0000028823-17-000146 · wf-form4_151371978248165.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,603 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:32 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | PurchaseCommon Shares | 700 | $18.13 | $12,687.50 |
DisclosureSEC source: 0000028823-17-000128 · wf-form4_150360674935616.xml · nonDerivative · entry 3 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,603 F1 · balance_after: Number includes Deferred Shares. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:32 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | PurchaseCommon Shares | 300 | $18.15 | $5,444.16 |
DisclosureSEC source: 0000028823-17-000128 · wf-form4_150360674935616.xml · nonDerivative · entry 2 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,903 F1 · balance_after: Number includes Deferred Shares. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:32 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | PurchaseCommon Shares | 4,000 | $18.14 | $72,572.40 |
DisclosureSEC source: 0000028823-17-000128 · wf-form4_150360674935616.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,603 F1 · balance_after: Number includes Deferred Shares. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:35 UTC | CROSS COUNTRY HEALTHCARE INC CCRN · Entity 13881 | GrantCommon Stock (restricted) | 9,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-17-000460 · edgar.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,560 F1 · security: The restricted shares of common stock will vest in three equal installments. The installments will vest on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| April 26, 2017 Filed Apr 28, 2017 21:18 UTC | DIEBOLD NIXDORF, Inc DBD · Entity 4421 | GrantCommon Shares | 5,164 | $0.00 | $0.00 |
DisclosureSEC source: 0000028823-17-000080 · wf-form4_149341426534998.xml · nonDerivative · entry 1 FITZGERALD GALE S · CIK 0001013804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,603 F1 · shares: Award of Deferred Shares F2 · balance_after: Number includes Deferred Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.